Safety
Predictable, manageable and reversible side effects while maintaining quality of life 6
As with any medication, side effects may occur when using the combination therapy Tafinlar® (dabrafenib) and Mekinist® (trametinib). The side...
Did you mean: sustained?
- Twitter Linkedin Facebook Pinterest Google plus
CAR-T talks: bridging therapy during CAR-T manufacturing
Patients referred for CAR-T therapy have active relapsed/refractory disease and are therefore at high risk of disease progression during the CAR-T manufacturing. In order to prevent clinically significant disease progression during this...
Twitter Linkedin Facebook Pinterest Google plusDosing / Administration
Posology 1Revolade dosing requirements must be individualised based on the patient's platelet counts. The lowest dose of eltrombopag to achieve and maintain a platelet count ≥50,000/µl should be used,...
Twitter Linkedin Facebook Pinterest Google plusEfficacy
Immune (primary) thrombocytopenia (ITP) studies 1Two phase III, randomised, double-blind, placebo-controlled studies RAISE (TRA102537) and TRA100773B and two open-label studies REPEAT (TRA108057) and EXTEND (TRA105325)...
Twitter Linkedin Facebook Pinterest Google plusNovartis Kisqali® delivers consistently superior overall survival – MONALEESA-3 trial demonstrates more life for postmenopausal HR+/HER2- advanced breast cancer patients
In MONALEESA-3, Kisqali plus fulvestrant achieved statistically significant overall survival benefit vs. fulvestrant alone in postmenopausal women (HR=0.724; p=0.00455)1 Kisqali is the only CDK4/6 inhibitor to demonstrate positive overall survival in two...Twitter Linkedin Facebook Pinterest Google plus
×